Literature DB >> 20653683

Lethal outcome of 5-fluorouracil infusion in a patient with a total DPD deficiency and a double DPYD and UTG1A1 gene mutation.

Hélène Mounier-Boutoille, Michèle Boisdron-Celle, Estelle Cauchin, Jean-Paul Galmiche, Alain Morel, Erick Gamelin, Tamara Matysiak-Budnik.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20653683      PMCID： PMC2911560          DOI： 10.1111/j.1365-2125.2010.03686.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  20 in total

1.  Lethal outcome of a patient with a complete dihydropyrimidine dehydrogenase (DPD) deficiency after administration of 5-fluorouracil: frequency of the common IVS14+1G>A mutation causing DPD deficiency.

Authors:  A B van Kuilenburg; E W Muller; J Haasjes; R Meinsma; L Zoetekouw; H R Waterham; F Baas; D J Richel; A H van Gennip
Journal:  Clin Cancer Res       Date:  2001-05       Impact factor: 12.531

2.  Lethal 5-fluorouracil toxicity associated with a novel mutation in the dihydropyrimidine dehydrogenase gene.

Authors:  A B P van Kuilenburg; J W Baars; R Meinsma; A H van Gennip
Journal:  Ann Oncol       Date:  2003-02       Impact factor: 32.976

3.  Clinical implications of dihydropyrimidine dehydrogenase (DPD) deficiency in patients with severe 5-fluorouracil-associated toxicity: identification of new mutations in the DPD gene.

Authors:  A B van Kuilenburg; J Haasjes; D J Richel; L Zoetekouw; H Van Lenthe; R A De Abreu; J G Maring; P Vreken; A H van Gennip
Journal:  Clin Cancer Res       Date:  2000-12       Impact factor: 12.531

4.  Dihydropyrimidine dehydrogenase enzyme deficiency: clinical and genetic assessment of prevalence in Turkish cancer patients.

Authors:  Ismail Celik; Ayşe Kars; Dicle Guc; Gülten Tekuzman; Sevket Ruacan
Journal:  Cancer Invest       Date:  2002       Impact factor: 2.176

5.  Relevance of different UGT1A1 polymorphisms in irinotecan-induced toxicity: a molecular and clinical study of 75 patients.

Authors:  Elisabeth Rouits; Michèle Boisdron-Celle; Agnès Dumont; Olivier Guérin; Alain Morel; Erick Gamelin
Journal:  Clin Cancer Res       Date:  2004-08-01       Impact factor: 12.531

6.  Denaturing high performance liquid chromatography analysis of the DPYD gene in patients with lethal 5-fluorouracil toxicity.

Authors:  Hany Ezzeldin; Martin R Johnson; Yoshihiro Okamoto; Robert Diasio
Journal:  Clin Cancer Res       Date:  2003-08-01       Impact factor: 12.531

Review 7.  Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil.

Authors:  André B P van Kuilenburg
Journal:  Eur J Cancer       Date:  2004-05       Impact factor: 9.162

8.  High prevalence of the IVS14 + 1G>A mutation in the dihydropyrimidine dehydrogenase gene of patients with severe 5-fluorouracil-associated toxicity.

Authors:  André B Van Kuilenburg; Rutger Meinsma; Lida Zoetekouw; Albert H Van Gennip
Journal:  Pharmacogenetics       Date:  2002-10

9.  Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile.

Authors:  G D Heggie; J P Sommadossi; D S Cross; W J Huster; R B Diasio
Journal:  Cancer Res       Date:  1987-04-15       Impact factor: 12.701

10.  Dihydropyrimidine dehydrogenase deficiency and fluorouracil-related toxicity.

Authors:  G Milano; M C Etienne; V Pierrefite; M Barberi-Heyob; R Deporte-Fety; N Renée
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640
View more
  5 in total

1.  Comparison of 4 Screening Methods for Detecting Fluoropyrimidine Toxicity Risk: Identification of the Most Effective, Cost-Efficient Method to Save Lives.

Authors:  Olivier Capitain; Valérie Seegers; Jean-Philippe Metges; Roger Faroux; Claire Stampfli; Marc Ferec; Tamara Matysiak Budnik; Hélène Senellart; Valérie Rossi; Nadège Blouin; Jonathan Dauvé; Mario Campone
Journal:  Dose Response       Date:  2020-09-14       Impact factor: 2.658

2.  A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant.

Authors:  Vincenzo De Falco; Maria Iole Natalicchio; Stefania Napolitano; Nicola Coppola; Giovanni Conzo; Erika Martinelli; Nicoletta Zanaletti; Pasquale Vitale; Emilio Francesco Giunta; Maria Teresa Vietri; Pietro Paolo Vitiello; Davide Ciardiello; Anna Marinaccio; Ferdinando De Vita; Fortunato Ciardiello; Teresa Troiani
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

3.  High-resolution melting analysis of the common c.1905+1G>A mutation causing dihydropyrimidine dehydrogenase deficiency and lethal 5-fluorouracil toxicity.

Authors:  Emma Borràs; Emma Dotor; Angels Arcusa; Maria J Gamundi; Imma Hernan; Miguel de Sousa Dias; Begoña Mañé; José A G Agúndez; Miguel Blanca; Miguel Carballo
Journal:  Front Genet       Date:  2013-01-17       Impact factor: 4.599

Review 4.  Delayed Presentation of DPD Deficiency in Colorectal Cancer.

Authors:  Lindsey Law; Jane Rogers; Cathy Eng
Journal:  J Adv Pract Oncol       Date:  2014-05

Review 5.  Severe Gastrointestinal Disorder Due to Capecitabine Associated with Dihydropyrimidine Dehydrogenase Deficiency: A Case Report and Literature Review.

Authors:  Yuya Hagiwara; Yoshiyuki Yamamoto; Yuki Inagaki; Reina Tomisaki; Miki Tsuji; Soma Fukuda; Satoshi Fukuda; Tsubasa Onoda; Hirosumi Suzuki; Yusuke Niisato; Yoshitaka Tange; Naoya Ikeda; Keiichi Yamada; Mariko Kobayashi; Daisuke Akutsu; Takeshi Yamada; Toshikazu Moriwaki; Toshiaki Narasaka; Hideo Suzuki; Kiichiro Tsuchiya
Journal:  Intern Med       Date:  2022-02-01       Impact factor: 1.282
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.